
Cameron Louttit, Ph.D.
Director of Life SciencesCameron Louttit, Ph.D. is Director of Life Sciences for Charlotte Lozier Institute, where he utilizes his background as a biomedical researcher and educator in support of scientific advances which honor the dignity of all human life.
Cameron received his B.S. in Biomedical Engineering from the University of Virginia, where he was a Jefferson and Rodman Scholar. He pursued graduate study at the University of Michigan and there received his M.S.E. and Ph.D. in Biomedical Engineering. His thesis research encompassed the development of both in vitro assay and therapeutic platforms to explore and modulate the role of the innate immune system in a variety of pathologies. A trainee of the Cellular Biotechnology Training Program and the recipient of a fellowship from the Department of Education, his curricular and extracurricular efforts beyond this thesis work focused particularly on the biotechnology industry and science/engineering pedagogy.
After completing his Ph.D., Cameron joined the teaching faculty at Michigan as a Lecturer of Biomedical Engineering. In this role, he taught undergraduate courses covering topics including medical device design, computational modeling and simulation, biomechanics, and statistics. He also served in an advising capacity for design teams and individual students navigating their biomedical training. Throughout this work, he pursued personal and professional development in instructional innovation, scientific communication, and bioethics.
Research Authored
Are Abortion Drugs Really Safer than Tylenol?
CLI executive director Karen Czarnecki sits down with CLI Director of Life Sciences Cameron Louttit, Ph.D., to discuss his Safety Claims paper.
Karen Czarnecki
Cameron Louttit, Ph.D.
Determining the Period Prevalence and Acuity of Emergency Department Visits Following Induced Abortion Mistakenly Identified as Spontaneous Abortion: An Analytic Observational Prospective Cohort Study
Coincident with the increasing dominance of medical abortion, there is a concurrent increase in the misattribution of post-induced abortion emergency department visits to a spontaneous abortion. High levels of visit acuity suggest that these miscodes represent a serious risk factor. Further, these miscodes mask post-abortion complication rates and undermine both the science and medical management necessary to address these issues.
The Origins and Proliferation of Unfounded Comparisons Regarding the Safety of Mifepristone
This paper systematically examines, and refutes, claims to the effect that the abortion drug mifepristone is as safe as Tylenol or other common medications.

